Multiplexed assay technology to speed up diagnostics
This article was originally published in Clinica
In a move that could lead to thousands of tests being performed in a single sample tube, a UK firm is applying its particle-labelling technology to autoimmune disease diagnosis.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.